Axonal-Biostatem has been delivering top-notch management of clinical and epidemiological research projects in France and Europe for more than 30 years. Axonal-Biostatem is a full services CRO providing all services internally and able to integrally perform a study from protocol design to the production of reports and publications. Axonal-Biostatem supports the pharmaceutical and medical device industries, biotechnology companies and even academic sponsors in the management of clinical trials and studies (Phases I to IV, early access program, post inscription or pharmaco-epidemiological studies (eventually linked to SNDS), Post Market Clinical Follow-up for medical devices, surveys, observatories...). Axonal-Biostatem is a Docaposte subsidiary.